Navigation Links
Open access to large-scale drug discovery data
Date:7/23/2008

The Wellcome Trust has awarded 4.7 million (5.8 million) to EMBL's European Bioinformatics Institute (EMBL-EBI) to support the transfer of a large collection of information on the properties and activities of drugs and a large set of drug-like small molecules from publicly listed company Galapagos NV to the public domain. It will be incorporated into the EMBL-EBI's collection of open-access data resources for biomedical research and will be maintained by a newly established team of scientists at the EMBL-EBI. These data lie at the heart of translating information from the human genome into successful new drugs in the clinic.

The human genome sequence provided a molecular 'parts list' for a human being, comprising all the genes and proteins that are encoded by our genetic blueprint. But to develop new medicines, it is important to catalogue how each of these 'parts' interacts with drugs and drug-like molecules. This interface of the genome with chemistry is a core part of the new scientific area of chemogenomics. For the past eight years, researchers at BioFocus DPI, the service division of Galapagos, have been integrating the existing collections of information in these two areas to develop a set of well-structured chemogenomic databases that can be used to help determine whether a particular molecule has the right properties to make an effective drug. BioFocus DPI licensed this information to pharmaceutical and biotech companies worldwide. As part of the Wellcome Trust grant announced today, the EBI will obtain the rights to the databases from BioFocus DPI. The award will make it possible to provide free access to this information for all researchers. "The scientific community worldwide will greatly benefit from unrestricted access to these data. It will aid their efforts in predictive drug discovery," says Galapagos CEO Onno van de Stolpe. "Galapagos has successfully accelerated its research programmes with these, and BioFocus DPI used the data to d
'/>"/>

Contact: Cath Brooksbank
cath@ebi.ac.uk
44-122-349-2525
European Molecular Biology Laboratory
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Silicon Valley Technology Leaders LaserCard Corporation and Tesla Motors Sign LaserPass Secure Access Deal
2. Mandate for public access to NIH-funded research poised to become law
3. UK research community gets extended access to ScienceDirect
4. Nationwide Childrens Hospital involved in expanded access program for treatment of PKU
5. Easton, PA Police Officers Armed With BIO-key(R) Mobile Data Solution Access Information Anytime, Anywhere
6. SAGE and Hindawi announce landmark open access agreement
7. Top physics laboratories sign up to open access with PhysMath Central
8. Open-access tropical conservation journal launches
9. Excellence in open access research celebrated at BioMed Central awards dinner
10. New chlorine-tolerant, desalination membrane hopes to boost access to clean water
11. Microarray sequence capture speeds large-scale resequencing of targeted genomic regions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...er 26, 2009) Whitehead researchers have developed...inpoint specific genes and proteins used by pathog... most human cell cultures genes are present in two...m the mother. Gene inactivation by mutation is the...vated, the second copy usually remains active and ...
(Date:11/26/2009)...ant Staphylococcus Aureus ) and other drug-resist...ature plasma prototype devices have been developed...idal cocktails. , Two prototype devices have bee...lthy skin (e.g. hands and feet) in hospitals and p...at; and another to shoot bacteria-killing agents i...
(Date:11/25/2009)...ced in the stomach, may be used to boost resistanc...ase, Yale School of Medicine researchers report in...al of Neuroscience . , Parkinson,s disease is ca...rea of the midbrain known as the substantia nigra,...duced production of dopamine in late-stage Parkins...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Emerson Ecologics Expands Their Team of Naturopathic Doctors 51718 1Emerson Ecologics Expands Their Team of Naturopathic Doctors 51718 2Vasogen Announces Second Quarter 2009 Results 13030 1Vasogen Announces Second Quarter 2009 Results 13030 2Vasogen Announces Second Quarter 2009 Results 13030 3Vasogen Announces Second Quarter 2009 Results 13030 4Vasogen Announces Second Quarter 2009 Results 13030 5Vasogen Announces Second Quarter 2009 Results 13030 6Vasogen Announces Second Quarter 2009 Results 13030 7Vasogen Announces Second Quarter 2009 Results 13030 8Vasogen Announces Second Quarter 2009 Results 13030 9Vasogen Announces Second Quarter 2009 Results 13030 10Educated Parkinsons Patients Move to Meds Sooner 51713 1Educated Parkinsons Patients Move to Meds Sooner 51713 2
...sh virus has been found for the first time in a va...d States by Cornell University researchers. , Acc...gram at Cornell,s College of Veterinary Medicine, ...ch causes fatal anemia and hemorrhaging in many fi... poses no threat to humans. , In May 2006, the ...
... at the University of California, San Diego and th...t time a web of inter-related responses that cells... being exposed to a powerful chemical mutagen. Th...Ideker describe in the May 19 issue of Science an ... by chemical damage to DNA. , "This research sheds...
...entists have linked a chemical that plays an essen...mage and male infertility, the 22nd annual confere...heard today (Monday). , Dr Iraj Amiri, embryology ...spital, Hamadan, Iran, said: "In recent years nitr...at plays an important role in regulating the biolo...
Other Biology News:Cornell researchers find serious fish virus in Northeast for first time 2Heal thyself: Systems biology model reveals how cells avoid becoming cancerous 2Heal thyself: Systems biology model reveals how cells avoid becoming cancerous 3Study links high levels of nitric oxide to infertility and sperm DNA damage 2
(Date:12/1/2009)... EpiVax, Inc. today announced a collaborative ...: RHHBY) aimed at evaluating EpiVax’s propri...y reduce detrimental immune responses to certain d...ion, the EpiVax Tregitope technology will be evalu...tein therapeutics. , (Voc...
(Date:12/1/2009)...OLIS and NORTH VANCOUVER, British Columbia, Dec. 1... wholly owned subsidiary of The Dow Chemical Compa...today announced the signing of a research and comm...vides Dow AgroSciences with access to Agrisoma,s p...on an exclusive basis in major food crops, and on ...
(Date:12/1/2009)... DNA Genotek, a leading provider of products f...hat Tepnel Pharmaceutical Services will offer Orag... nucleic acid extraction and genotyping service. ...ber 1, 2009 -- DNA Genotek , a leading provider o... announced that Tepnel Pharmaceutical Services w...
(Date:12/1/2009)... Michael R. Drapp, a 34-year veteran of the hi... Technologies, a business development and intellec...erging nanotechnology space. The company also pla...a nanotechnology incubator. , ...hael R. Drapp , a 34-year veteran of the high-tech...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4
... article, we looked at the leading pharmaceutical ...ical market, which for the first time surpassed $...art of equation, as another significant market is ...ve numbers on the size of the total medical device...d $200 billion in annual revenue in 2005, as the t...
.... - SecurePipe , an Illinois-based provider of n...ork operations center in Madison and more than 50 ...t of two new senior executives to its core managem...sales for the Atlanta-based Internet security serv...the new senior vice president of sales and busines...
... ,90s, a constant parade of start-ups came through...monetizing eyeballs" and revenue sharing to genera...We all know how that story ended: companies - eBay...hat presented a strong value proposition to consum...ther companies for their businesses, more or less,...
Other Biology Technology:Midwest retains dominant role in 2005 world medical device market 2Midwest retains dominant role in 2005 world medical device market 3Midwest retains dominant role in 2005 world medical device market 4Midwest retains dominant role in 2005 world medical device market 5Midwest retains dominant role in 2005 world medical device market 6Midwest retains dominant role in 2005 world medical device market 7SecurePipe appoints two senior execs 2Searching for revenue streams 2Searching for revenue streams 3
Anti-Ezrin / Radixin / Moesin Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-mSmac/DIABLO (CT) Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-Human ADAMTS16 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human acetyl-Histone H3 (Lys 4) Antibody, Unconjugated from Upstate
Biology Products: